Method and device for immunoassay using nucleotide conjugates

• US 8,445,199 B2
• Filed: 12/30/2009
• Issued: 05/21/2013
• Est. Priority Date: 12/31/2008
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Collier, Gordon Bruce, Miller, Cary James
• Primary Examiner(s): BROWN, MELANIE YU
• Application Number:
  US12/650,241
• Publication Number:
  US 20100167301A1
• Time in Patent Office: 1,238 Days
• Field of Search: 435/6.1, 435/6.11, 435/91.1, 435/7.9, 435/174
• US Class Current: 435/6.1
• CPC Class Codes: G01N 2458/10 Oligonucleotides as tagging agents for labelling antibodies
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/5306 Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
• CPC Class Codes: G01N 33/58 involving labelled substances G01N33/53 takes precedence
• CPC Class Codes: G01N 33/6887 from muscle, cartilage or connective tissue

Abstract

A composition of matter for use in an immunoassay devices and method comprising a signal antibody, e.g., FAB fragment, covalently linked to a first nucleotide; and one or more signal elements, e.g., signal enzymes such as ALP or fluorescent dyes, each covalently linked to a second nucleotide, wherein the first nucleotide has one or more repeated sequences, and the second nucleotide is bound to one of the one or more repeated sequences on said first nucleotide, and wherein the ratio of the signal antibody to the signal element is controlled by the number of repeated sequences.

Claims

1. A composition comprising:

a FAB fragment disposed in a solubilizing agent and covalently linked to a first nucleotide; and

one or more signal elements each covalently linked to a second nucleotide,

wherein;

said first nucleotide has one or more repeated sequences,

the second nucleotide is bound to one of the one or more repeated sequences on said first nucleotide,

the ratio of the FAB fragment to the signal element is controlled by the number of repeated sequences,

the solubilizing agent is a matrix configured to be disposed within a conduit of a device configured to perform an immunoassay, and

a 3′

-end or 5′

-end of the first nucleotide and the second nucleotide is protected from endogenous exonuclease activity from a blood sample within the conduit by incorporating a protective chemical group.

2. The composition according to claim 1, wherein the one or more signal elements comprise a non-enzymatic detection moiety that is selected from the group consisting of fluorescent, colorimetric, and radioactive elements.

3. The composition according to claim 1, wherein the one or more signal elements comprise one or more signal enzymes.

4. The composition according to claim 3, wherein the first nucleotide and second nucleotide contain a coupling moiety at the 5′

end, 3′

end or internal to the nucleotide sequence.

5. The composition according to claim 4, wherein the coupling moiety is generated from a modified phosphoramidite selected from the group consisting of an amino modifier, thiol modifier, and dithiol.

6. The composition according to claim 1, wherein the protective chemical group is a phosphorothioate.

7. The composition according to claim 3, wherein the one or more signal enzymes are selected from the group consisting of alkaline phosphatase, glucose oxidase, lactate oxidase, urease, horseradish peroxidase, galactose oxidase, and beta-galactosidase.

8. The composition according to claim 3, wherein the first nucleotide has at least three repeated sequences which bind to at least three of the second sequences of at least three of the one or more signal enzymes.

9. The composition according to claim 3, wherein the first nucleotide has at least five repeated sequences which bind to at least five of the second sequences of at least three of the one or more signal enzymes.